What is King Pharmaceuticals's international — year 2?

King Pharmaceuticals (KG) reported international — year 2 of 6.9% in Q4 2025.

What does international — year 2 mean?

This metric represents the second year of the loss development cycle for the international segment, providing a view of claim maturity and reserve adequacy one year after the initial reporting period. It helps actuaries refine loss projections by comparing actual development against initial expectations. Consistent performance in this year is a key indicator of stable underwriting and reserving practices.

King Pharmaceuticals KG International — Year 2

Other product segments

All other lines

32.4%—

Commercial Auto Liability

17.6%—

General Liability

10.4%—

European Hospital Liability

7.1%—

Similar metrics at other companies

CNAInternational — Year 2

22.6%—

AXSInsurance — Year 2

38.8%—

GLREFinancial — Year 2

51.6%-15.6pp

GLREHealth — Year 2

83%+0.2pp

CNAInternational — Year 1

15%—

EGProperty Insurance — Year two

59.2%-2.4pp

Other financials

Income statement

See full

Revenue$10.2M+1,112%

Net income-$7.4M-1,786%

EPS (diluted)-$0.96-586%

Balance sheet

See full

Cash & equivalents$62.2M+1,724%

Total debt$176.7M—

Total equity$121.4M+2,773%

Total assets$964.2M—

Cash flow

See full

Operating cash flow-$15.1M-1,628%

Valuation

See full

Market cap$70.42M-67.6%

Enterprise value$184.93M-50.0%

P/E1.2×—

P/S1.6×-24.3×

Profitability

See full

Net margin131.5%—

Returns & leverage

See full

Return on equity90.8%—

Debt / equity1.5×—

Where this comes from

Reported directly by King Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:ShortdurationInsuranceContractsHistoricalClaimsDurationYearTwo.

The official record: King Pharmaceuticals’s 10-K, filed March 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about King Pharmaceuticals's international — year 2.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI

Claude

Questions, answered.

What is King Pharmaceuticals's international — year 2?: King Pharmaceuticals (KG) reported international — year 2 of 6.9% in Q4 2025.
What does international — year 2 mean?: This metric represents the second year of the loss development cycle for the international segment, providing a view of claim maturity and reserve adequacy one year after the initial reporting period. It helps actuaries refine loss projections by comparing actual development against initial expectations. Consistent performance in this year is a key indicator of stable underwriting and reserving practices.